FBLG FibroBiologics, Inc. - Common Stock
$1,20
Precio · Ago 19, 2026
Fundamentales a fecha de Jul 31, 2026
Rango 52S
$0–$5
19% of range
Calificación del Analista
BUY
7 analysts
Precio Objetivo
$12
+946% upside
P/E (TTM)
-0.5
ROE
—
Margen de Beneficio Neto
—
FBLG Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$1.20
Capitalización Bursátil
—
P/E (TTM)
-0.5
BPA (TTM)
$-0.42
Ingresos (TTM)
—
Rendimiento div.
—
ROE
—
Deuda/Capital
—
Rango 52S
$0 – $5
FBLG Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
Configure
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos y Beneficio Neto
—
BPA
$-0.42
2022-12-31
→
2025-12-31
Flujo de caja libre
—
2023-12-31
→
2024-12-31
Márgenes
—
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
Métrica
Tendencia a 5 años
FBLG
Mediana de Pares
P/E (TTM)
-0.5
—
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
Métrica
Tendencia a 5 años
FBLG
Mediana de Pares
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
Métrica
Tendencia a 5 años
FBLG
Mediana de Pares
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Métrica
Tendencia a 5 años
FBLG
Mediana de Pares
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Métrica
Tendencia a 5 años
FBLG
Mediana de Pares
FBLG Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
COMPRA
7 analistas
- Compra fuerte 2 28,6%
- Compra 4 57,1%
- Mantener 1 14,3%
- Venta 0 0,0%
- Venta fuerte 0 0,0%
Precio objetivo a 12 meses
2 analistas · 2026-08-19
Mediana
$12.50
← Por Debajo de Todos los Objetivos
$1.20
Mín
$6.00
Máx
$19.00
Objetivo mediano
$12.50
+946,0%
Objetivo medio
$12.50
+946,0%
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
0.03%
| Período | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|
| 30 de junio de 2026 | $-0.66 | $-0.73 | 0.07% |
| 31 de marzo de 2026 | $-1.33 | $-1.33 | -0.00% |
| 31 de diciembre de 2025 | $-0.60 | $-1.78 | 1.2% |
| 30 de septiembre de 2025 | $-2.60 | $-2.19 | -0.41% |
| 30 de junio de 2025 | $-2.40 | $-2.29 | -0.10% |
| 31 de marzo de 2025 | $-2.80 | $-2.24 | -0.56% |
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| FBLG | — | -0.5 | — | — | — | — |
| AQB | $4M | -0.2 | -21.2% | — | -315.5% | — |
| ALZN | $5M | -0.4 | — | — | -598.1% | — |
| ERNA | — | — | — | — | — | — |
| ENSC | $4M | -0.2 | -2.8% | -200.9% | -294.0% | — |
| BOLT | $11M | -0.3 | 0.07% | -433.7% | -102.2% | — |
| CDIO | — | — | — | — | — | — |
| ACXP | $6M | -0.5 | — | — | -180.3% | — |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados 14
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| R&D Expense | $7M | $5M | $2M | $1M | |
| SG&A Expense | $9M | $9M | $7M | $3M | |
| Operating Expenses | $17M | $14M | $9M | $4M | |
| Operating Income | $-17M | $-14M | $-9M | $-4M | |
| Interest Expense | · | · | $147.0K | $654.0K | |
| Interest Income | $247.0K | $251.0K | · | · | |
| Other Non-op | $-619.0K | $32.0K | $-213.0K | · | |
| Income Tax | $0 | $0 | $0 | $0 | |
| Net Income | $-19M | $-11M | $-16M | $-5M | |
| EPS (Basic) | $-0.42 | $-0.34 | $-0.68 | $-0.18 | |
| EPS (Diluted) | $-0.42 | $-0.34 | $-0.68 | $-0.18 | |
| Shares (Basic) | 44,660,518 | 32,875,075 | 28,230,842 | 28,230,842 | |
| Shares (Diluted) | 44,660,518 | 32,875,075 | 28,230,842 | 28,230,842 | |
| EBITDA | · | $-14M | $-9M | · |
Balance general 19
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $14M | $9M | $2M | |
| Receivables | · | · | · | $300.0K | |
| Prepaid Expense | $1M | $225.0K | $36.0K | $29.0K | |
| Other Current Assets | $0 | $18.0K | $16.0K | $30.0K | |
| Current Assets | $6M | $14M | $9M | $3M | |
| PP&E (Net) | $842.0K | $824.0K | $797.0K | · | |
| PP&E (Gross) | $1M | $1M | $844.0K | · | |
| Accum. Depreciation | $448.0K | $204.0K | $47.0K | · | |
| Total Assets | $10M | $16M | $12M | $5M | |
| Accounts Payable | $945.0K | $3M | $1M | $758.0K | |
| Short-term Debt | $0 | $9M | · | · | |
| Current Liabilities | $2M | $13M | $9M | $7M | |
| Capital Leases | $2M | $984.0K | $1M | $2M | |
| Total Liabilities | $3M | $14M | $11M | $9M | |
| Common Stock | $1.0K | $0 | · | · | |
| Paid-in Capital | $60M | $38M | $26M | $2M | |
| Retained Earnings | $-54M | $-36M | $-24M | $-8M | |
| Stockholders' Equity | $6M | $3M | $1M | $-4M | |
| Liabilities + Equity | $10M | $16M | $12M | $5M |
Flujo de Efectivo 10
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $265.0K | |
| Operating Cash Flow | $-16M | $-12M | $-6M | $-4M | |
| CapEx | $262.0K | $184.0K | $495.0K | · | |
| Investing Cash Flow | $-262.0K | $-184.0K | $-495.0K | · | |
| Stock Issued | $7M | $8M | · | · | |
| Net Stock Activity | · | $8M | · | · | |
| Financing Cash Flow | $8M | $17M | $14M | $6M | |
| Net Change in Cash | $-9M | $5M | $7M | $2M | |
| Taxes Paid | $0 | $0 | · | · | |
| Free Cash Flow | · | $-12M | $-7M | · |
Rentabilidad 2
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| ROA | · | -79.0% | -198.1% | · | |
| ROE | · | -407.9% | -279.6% | · |
Liquidez y Solvencia 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 1.1 | 1.0 | · | |
| Quick Ratio | · | 1.1 | 1.0 | · | |
| Interest Coverage | · | · | -60.5 | · |
Valoración (TTM) 3
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Net Income TTM | $-19M | $-11M | $-16M | · | |
| P/E | -0.5 | -5.9 | · | · | |
| Earnings Yield | -186.7% | -17.0% | · | · |
Estado de resultados 14
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $3M | $797.0K | $3M | $2M | $2M | $1M | $1M | $975.0K | $960.0K | $772.0K | $547.0K | $478.0K | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $5M | $3M | $5M | $4M | $5M | $4M | $3M | $3M | $3M | $2M | $2M | $2M | |
| Operating Income | $-4M | $-5M | $-3M | $-5M | $-4M | $-5M | $-4M | $-3M | $-3M | $-3M | $-2M | $-2M | $-2M | |
| Interest Expense | · | · | · | · | · | · | · | · | $5.0K | $4.0K | · | $10.0K | $135.0K | |
| Interest Income | $15.0K | $20.0K | $25.0K | $73.0K | $50.0K | $99.0K | $63.0K | $79.0K | $70.0K | $39.0K | · | · | · | |
| Other Non-op | $-92.0K | $-2.0K | $6.0K | $0 | $-625.0K | $0 | $1.0K | $2.0K | $30.0K | · | $0 | $-57.0K | $-15.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | · | · | · | |
| Net Income | $-4M | $-5M | $-3M | $-6M | $-5M | $-5M | $-3M | $-500.0K | $898.0K | $-8M | $-10M | $-2M | $-2M | |
| EPS (Basic) | $-0.66 | $-1.33 | $-0.03 | $-0.13 | $-2.41 | $-2.71 | $-0.09 | $-0.01 | $0.03 | $-0.27 | $-0.34 | $-0.08 | $-0.18 | |
| EPS (Diluted) | $-0.66 | $-1.33 | $-0.03 | $-0.13 | $-2.41 | $-2.71 | $-0.09 | $-0.01 | $0.03 | $-0.27 | $-0.34 | $-0.08 | $-0.18 | |
| Shares (Basic) | 6,272,541 | 3,772,930 | -73,720,414 | 43,072,542 | 1,931,763 | 1,833,656 | -64,494,468 | 33,516,656 | 32,719,125 | 31,133,762 | -56,461,684 | 28,230,842 | 28,230,842 | |
| Shares (Diluted) | 6,272,541 | 3,772,930 | -73,720,414 | 43,072,542 | 1,931,763 | 1,833,656 | -64,494,468 | 33,516,656 | 32,719,125 | 31,133,762 | -56,461,684 | 28,230,842 | 28,230,842 | |
| EBITDA | $-4M | $-5M | · | $-5M | $-4M | $-5M | · | $-3M | $-3M | $-3M | · | · | · |
Balance general 19
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $1M | $5M | $5M | $9M | $9M | $14M | $8M | $6M | $8M | $9M | · | · | |
| Prepaid Expense | $528.0K | $1M | $1M | $373.0K | $1M | $642.0K | $225.0K | $353.0K | $518.0K | $746.0K | $36.0K | · | · | |
| Other Current Assets | · | $403.0K | $0 | · | · | $18.0K | $18.0K | $18.0K | $18.0K | $18.0K | $16.0K | · | · | |
| Current Assets | $6M | $3M | $6M | $5M | $10M | $9M | $14M | $8M | $7M | $9M | $9M | · | · | |
| PP&E (Net) | $710.0K | $776.0K | $842.0K | $908.0K | $967.0K | $814.0K | $824.0K | $772.0K | $799.0K | $770.0K | $797.0K | · | · | |
| PP&E (Gross) | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $929.0K | $918.0K | $852.0K | $844.0K | · | · | |
| Accum. Depreciation | $580.0K | $514.0K | $448.0K | $382.0K | $317.0K | $257.0K | $204.0K | $157.0K | $119.0K | $82.0K | $47.0K | · | · | |
| Total Assets | $8M | $6M | $10M | $9M | $14M | $11M | $16M | $10M | $9M | $11M | $12M | · | · | |
| Accounts Payable | $2M | $850.0K | $945.0K | $1M | $2M | $1M | $3M | $1M | $1M | $814.0K | $1M | · | · | |
| Short-term Debt | · | · | $0 | $5M | $8M | $6M | $9M | $115.0K | $287.0K | $459.0K | · | · | · | |
| Current Liabilities | $2M | $2M | $2M | $7M | $11M | $8M | $13M | $7M | $10M | $14M | $9M | · | · | |
| Capital Leases | $1M | $2M | $2M | $2M | $2M | $865.0K | $984.0K | $1M | $1M | $1M | $1M | · | · | |
| Total Liabilities | $3M | $3M | $3M | $9M | $13M | $9M | $14M | $8M | $11M | $15M | $11M | · | · | |
| Total Debt | · | · | · | $5M | $8M | $6M | · | $115.0K | $287.0K | $459.0K | · | · | · | |
| Common Stock | $1.0K | $1.0K | $1.0K | $0 | $0 | · | $0 | · | · | · | · | · | · | |
| Paid-in Capital | $68M | $62M | $60M | $51M | $46M | $43M | $38M | $35M | $30M | $29M | $26M | · | · | |
| Retained Earnings | $-63M | $-59M | $-54M | $-51M | $-45M | $-40M | $-36M | $-32M | $-32M | $-33M | $-24M | · | · | |
| Stockholders' Equity | $5M | $3M | $6M | $125.0K | $860.0K | $2M | $3M | $3M | $-2M | $-4M | $1M | · | · | |
| Liabilities + Equity | $8M | $6M | $10M | $9M | $14M | $11M | $16M | $10M | $9M | $11M | $12M | · | · |
Flujo de Efectivo 10
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $707.0K | $694.0K | $702.0K | $704.0K | $729.0K | $551.0K | $544.0K | $572.0K | $578.0K | $525.0K | $432.0K | $448.0K | $448.0K | |
| Operating Cash Flow | $-3M | $-4M | $-3M | $-4M | $-4M | $-5M | $-3M | $-3M | $-2M | $-4M | $-2M | $-2M | $-2M | |
| CapEx | $0 | $0 | $0 | $6.0K | $213.0K | $43.0K | $99.0K | $11.0K | $66.0K | $8.0K | $2.0K | $24.0K | $56.0K | |
| Investing Cash Flow | $0 | $0 | $0 | $-6.0K | $-213.0K | $-43.0K | $-99.0K | $-11.0K | $-66.0K | $-8.0K | $-2.0K | $-24.0K | $-56.0K | |
| Stock Issued | $3M | $706.0K | · | · | $0 | $0 | $45.0K | $5M | $0 | $3M | · | · | · | |
| Net Stock Activity | · | $706.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $5M | $952.0K | $3M | $0 | $4M | $0 | $9M | $4M | $-172.0K | $3M | $0 | $-2M | $15M | |
| Net Change in Cash | $2M | $-3M | $27.0K | $-4M | $178.0K | $-5M | $6M | $2M | $-2M | $-1M | $-2M | $-3M | $12M | |
| Taxes Paid | $0 | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | |
| Free Cash Flow | · | $-4M | · | · | · | $-5M | · | · | · | $-4M | · | · | · |
Rentabilidad 2
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -37.7% | -57.6% | · | -60.2% | -40.8% | -43.5% | · | -9.6% | 20.2% | -148.4% | · | · | · | |
| ROE | -149.8% | -202.0% | · | -403.8% | 610.1% | 656.4% | · | -36.5% | -75.2% | 438.0% | · | · | · |
Liquidez y Solvencia 4
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.6 | 1.6 | · | 0.8 | 0.9 | 1.1 | · | 1.2 | 0.6 | 0.6 | · | · | · | |
| Quick Ratio | 1.6 | 0.8 | · | 0.7 | 0.8 | 1.1 | · | 1.2 | 0.6 | 0.6 | · | · | · | |
| Debt / Equity | · | · | · | 36.6 | 9.4 | 2.5 | · | 0.0 | -0.1 | -0.1 | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | -644.8 | -862.5 | · | · | · |
Valoración (TTM) 3
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-20M | $-20M | · | $-16M | $-9M | $-13M | · | $-10M | $-12M | $-15M | · | · | · | |
| P/E | -0.2 | -0.3 | · | -1.4 | -2.6 | -2.3 | · | -9.4 | -12.5 | -17.7 | · | · | · | |
| Earnings Yield | -477.9% | -325.0% | · | -73.3% | -38.6% | -43.3% | · | -10.7% | -8.0% | -5.6% | · | · | · |
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
Estado de resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Beneficio neto | $-19M | $-11M | $-16M | $-5M |
| EPS Diluido | $-0.42 | $-0.34 | $-0.68 | $-0.18 |
Balance general
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Ratio corriente | — | 1.1 | 1.0 | — |
| Ratio Rápido | — | 1.1 | 1.0 | — |
Flujo de Efectivo
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | |
|---|---|---|---|---|
| Flujo de caja libre | — | $-12M | $-7M | — |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
📊
Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Propietarios institucionales (13F) 2 declarantes · $71K total · A fecha de 31 de diciembre de 2025
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Actividad institucional — Q4 2025 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 5 (-2 vs trimestre anterior) | 13 (+1 vs trimestre anterior) | 5 (-2 vs trimestre anterior) | 6 (-15 vs trimestre anterior) | -472K |
Comparado con Q3 2025. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Nuveen Asset Management, LLC | $69 080 | 34 540 | 96,62% | Acciones |
| VANGUARD GROUP INC | $2 416 | 10 736 | 3,38% | Acciones |
Informantes de la empresa 4 insiders · 0 directivos · 4 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Victoria Ninon Olivia Niklas | Consejero | 23 de junio de 2026 A | — | 0 | 0 | $0 |
| Richard C. Cilento Jr. | Consejero | 23 de junio de 2026 A | — | 0 | 0 | $0 |
| Matthew Link | Consejero | 23 de junio de 2026 A | — | 0 | 0 | $0 |
| Robert Hoffman | Consejero | 23 de junio de 2026 A | — | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 1 ETF
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 27 769 SH | 8 de agosto de 2026 | Diario |